What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His primary areas of study are Internal medicine, Adverse effect, Rash, Oncology and Dermatology.
His research combines Surgery and Internal medicine.
His Adverse effect research integrates issues from Gastroenterology, Multikinase inhibitor, Clinical efficacy, Clinical endpoint and Lung cancer.
His research in Rash intersects with topics in Mucositis, Incidence, Immunology, Nivolumab and Ipilimumab.
His research in the fields of Sunitinib overlaps with other disciplines such as Cell cycle checkpoint.
His study in Dermatology is interdisciplinary in nature, drawing from both EGFR inhibitors, Pharmacotherapy and Melanoma.
His most cited work include:
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies (735 citations)
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies (735 citations)
- Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (674 citations)
What are the main themes of his work throughout his whole career to date?
Mario E. Lacouture spends much of his time researching Internal medicine, Adverse effect, Oncology, Cancer and Dermatology.
His study looks at the relationship between Internal medicine and topics such as Surgery, which overlap with Sorafenib.
The study incorporates disciplines such as Pathology, Breast cancer, Immunotherapy and Intensive care medicine in addition to Adverse effect.
His Oncology research incorporates elements of Cetuximab, Colorectal cancer, Panitumumab, Chemotherapy and Epidermal growth factor receptor.
The various areas that he examines in his Cancer study include Discontinuation, Radiation therapy, Retrospective cohort study and Gastroenterology.
His work carried out in the field of Rash brings together such families of science as EGFR inhibitors, Ipilimumab and Immunology.
He most often published in these fields:
- Internal medicine (48.34%)
- Adverse effect (38.19%)
- Oncology (31.79%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (48.34%)
- Adverse effect (38.19%)
- Cancer (30.68%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Adverse effect, Cancer, Dermatology and Oncology.
His study explores the link between Adverse effect and topics such as Immune checkpoint inhibitors that cross with problems in Treatment outcome.
His Cancer research includes themes of Discontinuation, Quality of life, Radiation therapy and Hazard ratio.
His work in Dermatology covers topics such as Chemotherapy which are related to areas like Taxane.
His research on Oncology often connects related areas such as Tolerability.
His work deals with themes such as Toxic epidermal necrolysis and Graft-versus-host disease, which intersect with Rash.
Between 2017 and 2021, his most popular works were:
- Management of Immunotherapy-Related Toxicities, Version 1.2019. (170 citations)
- Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC. (112 citations)
- Efficacy of MEK inhibition in patients with histiocytic neoplasms (75 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
His primary scientific interests are in Internal medicine, Adverse effect, Cancer, Cancer research and Dermatology.
His Oncology research extends to the thematically linked field of Internal medicine.
His studies deal with areas such as Clinical trial, Chemotherapy, Epidermal growth factor receptor, Afatinib and Lung cancer as well as Adverse effect.
In his study, Severity of illness is strongly linked to Quality of life, which falls under the umbrella field of Cancer.
His research integrates issues of Kinase, MAPK/ERK pathway, Histiocytoses, Histiocytosis and PTEN in his study of Cancer research.
His work on Rash, Maculopapular rash, Hypertrichosis and Hair Disorder as part of general Dermatology research is frequently linked to Context, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
